Top 40 Editas Medicine investors
The most complete profiles first. Showing 40 of 61.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Alex GoldsmithVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Avak KahvejianVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more
Verified email available
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Ewen CameronVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Meredith FisherVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Molly GibsonVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nick PlugisVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Roger KittermanVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Sabrina YangVerified
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Sebastian TrousilVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Stephen BerensonVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Torben Straight NissenVerified
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Blake ByersVerified
Angel/Individual · United States
PaymentsLife ScienceConsumer InternetParkingPortfolio: MediaSpike, Ionic Security, Editas Medicine, Spruce Health and 7 more
Verified email available
Douglas ColeVerified
Venture Capital, Entrepreneurship Program · United States
Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Ignacio MartinezVerified
Venture Capital, Entrepreneurship Program · United States
Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more
Verified email available
Jim GilbertVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Carl Berke
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Eytan Weinstein
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Geoffrey von Maltzahn
Venture Capital, Entrepreneurship Program, Investor · United States
Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Harry Wilcox
Venture Capital, Investor · United States
Series AHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more
Contact details available
See all 61 Editas Medicine investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Editas Medicine investors are on Angel Roster?
Angel Roster lists 61 Editas Medicine investors. 30 of them (49%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (52), Private Equity Firms (10) and Entrepreneurship Programs (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Editas Medicine investors invest in?
Among those that list a stage, the most common are Seed (17), Series A (14) and Series B (5).
Where are Editas Medicine investors based?
Most are based in the United States (60) and Canada (1).
Which companies have Editas Medicine investors backed?
The most-backed portfolio companies among them are Syros Pharmaceuticals (42), Sesen Bio, Inc. (32), TARIS Biomedical (32), Agios Pharmaceuticals (32) and Seventh Sense Biosystems (32).
How do I contact Editas Medicine investors?
Create a free Angel Roster account to search and filter all 61, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.